Publication | Open Access

Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status

Plasma MethoxytyramineTumor BiologyGliomaMedicinePathologyAdrenal DiseaseOncologyRadiation OncologyRisk FactorsSdhb Mutation StatusCancer ResearchEndocrine-related CancerHealth Sciences